Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period (BMI)
|ClinicalTrials.gov Identifier: NCT01592058|
Recruitment Status : Completed
First Posted : May 4, 2012
Last Update Posted : July 31, 2012
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).
The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||427 participants|
|Official Title:||Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||May 2012|
|Actual Study Completion Date :||May 2012|
- Weight [ Time Frame: Baseline and 12 months ]Change in weight from baseline at 12 months.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01592058
|United States, Missouri|
|Washington University School of Medicine|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Tessa E Madden, MD, MPH||Washington University School of Medicine|